NICE u-turn on lipids guidance21st May 2008
NICE is to execute a "u-turn" in the guidance it produces for lipids and reverse its decision on the new risk score for cardiovascular disease.
The change follows severe criticism of the QRISK assessment system. Professor Julia Hippisley-Cox, QRISK researcher and professor of primary care at the University of Nottingham, asked: "Can NICE publish its equity impact assessment and if it hasn’t done one why not? Does it have any worries about widening health inequalities in our most disadvantaged communities?"
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.